Feature|Articles|August 13, 2026

Data Quality Across the Clinical Trial Lifecycle: What It Takes to Fully Trust Your Data

From point-of-care sample collection to real-world data curation, wearable device integration, and continuous review infrastructure, data quality is not a single problem in clinical trials—it is a layered challenge that manifests differently at every stage of development and demands a different set of solutions at each one.

Clinical trial modernization is moving fast, but the foundational problem has not changed: data quality remains the ceiling on everything else the industry is trying to build. Artificial intelligence, real-time oversight, and real-world evidence all depend on data that is accurate, complete, and trustworthy from the moment it is collected. That condition is still far from guaranteed across most of the clinical trial ecosystem.

Related to this article

Recruitment in the Age of AI: Q&A with John Worden, Javara
In this Q&A, John Worden, chief commercial officer at Javara, discusses why clinical trial recruitment has remained stubbornly one-size-fits-all, how AI can identify patients at scale without displacing the clinician relationships that drive trust, and what care-integrated research engagement needs to look like for health systems, sponsors, and sites.
© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.